跳至主要内容
临床试验/JPRN-jRCT1051210189
JPRN-jRCT1051210189招募中未知

A single-arm pilot study to evaluate changes in renal function and safety of steroid pulse therapy in renal transplant patients with advanced tertiary lymphoid tissues

Yanagita Motoko0 个研究点目标入组 30 人开始时间: 2022年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 75age old(—)
性别
All

入选标准

  • For primary enrollment, the following criteria must be met
  • 1) Patients who have undergone living donor kidney transplantation in Japan
  • 2) Patients scheduled to undergo protocol renal biopsy 1 year after kidney transplantation
  • 3) 18 to 75 years old, and at the time of consent/enrollment date
  • 4) Written consent has been obtained from the patient for study participation.
  • For secondary enrollment, the following criterion must be met
  • 1) Positive Advanced tertiary lymphoid tissues on renal biopsy 1 year after kidney transplantation

排除标准

  • Patients will be excluded from primary enrollment if they meet any of the following criteria
  • 1) Prior treatment with rituximab from perioperative to study enrollment
  • 2) No improvement in renal function after kidney transplantation (eGFR < 30 ml/min/1.73 m2 ) until study enrollment
  • 3) Previous diagnosis of BK virus nephropathy within 1 year after kidney transplant
  • 4) Pathologically diagnosed with acute rejection within 1 year of kidney transplant
  • 5) Patients who have received another organ transplant
  • 6) Patients suffering from serious infections and other serious complications
  • 7) Patients with poorly controlled diabetes mellitus (HbA1c >= 7.5%)
  • 8) Patients with poorly controlled glaucoma
  • 9) Patients with poorly controlled hypertension (systolic blood pressure >=160 mmHg or diastolic blood pressure >= 100 mmHg)
  • 10) Obesity (BMI >= 40 kg/m2)
  • 11) History of fracture due to osteoporosis
  • 12) History of severe drug allergy to steroids.
  • 13) Women who are pregnant or may become pregnant. Women who are lactating.
  • Patients will be excluded from secondary enrollment if they meet any of the following criteria
  • 1) Diagnosis of acute rejection by renal biopsy 1 year after kidney transplantation.
  • 2) Diagnosis of BK virus nephropathy by renal biopsy 1 year after kidney transplantation
  • 3) Diagnosis of nephritis or other lesions requiring therapeutic intervention by renal biopsy 1 year after kidney transplantation
  • 4) Patients who are judged unsuitable to conduct this study by the principal investigator or sub-investigator.

研究者

发起方
Yanagita Motoko

相似试验